The Chippenham-based company has an asthma drug on the market called Flutiform ... of GlaxoSmithKline's Advair (fluticasone propionate/salmeterol) partnered with Hikma, and other inhaled and ...

Teva has launched new digital inhaler and drug combination in the US ... s blockbuster inhaler Advair (fluticasone+salmeterol). The competition for the product approved in asthma and COPD ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year ...

PAH, or pulmonary hypertension, can leave someone breathless even after a short walk, but better drug combinations have ...

GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...

Vertex Pharmaceuticals Inc.’s non-addictive drug helped patients with lower back pain, moving the company closer to selling ...

The U.S. Food and Drug Administration has approved Novo Nordisk's drug for the prevention or reduction of bleeding episodes ...

Ozempic (semaglutide) has potential interactions with other drugs and some supplements. For example, Ozempic can interact with oral medications and some diabetes medications, including insulin.

Pain has really been out of favor in the industry up until very recently,” said John Mulcahy, SiteOne Therapeutics’ CEO. The ...